Option Care Health (NASDAQ:OPCH) Stock Rating Upgraded by Jefferies Financial Group

Option Care Health (NASDAQ:OPCH) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a report released on Thursday, Marketbeat.com reports. The brokerage presently has a $35.00 price objective on the stock, up from their prior price objective of $26.00. Jefferies Financial Group’s target price would suggest a potential upside of 19.41% from the company’s previous close.

A number of other analysts have also recently commented on the stock. JMP Securities restated a “market outperform” rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Barrington Research boosted their target price on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a report on Tuesday, January 14th. UBS Group assumed coverage on shares of Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $31.14.

Option Care Health Stock Performance

Shares of OPCH stock opened at $29.31 on Thursday. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63. The stock has a market cap of $4.99 billion, a PE ratio of 24.63, a price-to-earnings-growth ratio of 2.12 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company’s fifty day moving average price is $24.10 and its 200-day moving average price is $27.78.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was acquired at an average price of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 0.64% of the stock is owned by insiders.

Institutional Investors Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Pacer Advisors Inc. increased its position in shares of Option Care Health by 2.2% during the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock valued at $591,000 after purchasing an additional 537 shares during the last quarter. KBC Group NV increased its position in shares of Option Care Health by 46.4% during the 4th quarter. KBC Group NV now owns 7,337 shares of the company’s stock valued at $170,000 after purchasing an additional 2,324 shares during the last quarter. Blue Trust Inc. increased its position in shares of Option Care Health by 16.9% during the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock valued at $109,000 after purchasing an additional 681 shares during the last quarter. Whalen Wealth Management Inc. purchased a new stake in Option Care Health in the 4th quarter worth approximately $253,000. Finally, Avior Wealth Management LLC increased its holdings in Option Care Health by 4.8% in the 4th quarter. Avior Wealth Management LLC now owns 25,466 shares of the company’s stock worth $591,000 after acquiring an additional 1,166 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.